- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, May 7, 2021
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by The Hill cited a study published in the March 2021 issue of The American Journal of Managed Care® (AJMC®). The study, “Limiting Medicaid Access to Accelerated Approval Drugs: Costs and Consequences,” indicated that although accelerated approval drugs account for less than 1% of Medicaid spending, states seek CMS approval to avoid coverage of these drugs and cut costs.
A newscast by KX News referenced an article published on AJMC.com, the website of AJMC®. The article, “Diabetic Amputations May Be Rising in the United States,” highlighted that lower-limb amputations may be increasing in the United States after decades of decline, with approximately 230 reported amputations attributed to diabetes each day in the United States.
A piece by LeedsLive featured an article published on AJMC.com, titled, “How Much Does It Cost to Give Birth in the United States? It Depends on the State.” The article examined the cost of giving birth in the United States, finding that the price tag can vary by thousands of dollars depending on the state, with inpatient birth charges amounting to roughly $8300 in Arkansas compared with nearly $20,000 in New York.
An article posted on moms.com cited an article published on AJMC.com, titled, “Atopic Diseases Linked to Behavioral Difficulties in Children, Adolescents.” The piece spotlighted associations between atopic dermatitis and internalizing and externalizing problems among younger children with the condition, who experience emotional problems, and adolescents with other atopic diseases who have relationship issues.
Decisions and Precision in Value-Based Cancer Care
January 7th 2025An Institute for Value-Based Medicine regional event in Houston, Texas, covered inconsistencies with the integration of precision medicine in oncology practices, the evolution of treatment for multiple myeloma, and more.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Managed Care Reflections: A Q&A With Jan E. Berger, MD, MJ
January 7th 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The January issue features a conversation with longtime editorial board member Jan E. Berger, MD, MJ, the CEO of Health Intelligence Partners.
Read More
